← FDA Drug Approvals (Drugs@FDA)
XIFAXAN
NDA · New Drug Application · Sponsor: SALIX PHARMS · Approved 2004-05-25
Drug application
- FDA Application #
NDA021361- Application type
- New Drug Application
- Brand name
- XIFAXAN
- Generic name
- RIFAXIMIN
- Active ingredients
- RIFAXIMIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SALIX PHARMS
- Manufacturer
- Salix Pharmaceuticals, Inc.
- First approval
- 2004-05-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown